Jupiter Neurosciences Announces $2.0 Million Registered Direct Offering

On May 20, 2026, Jupiter Neurosciences, Inc. entered into a Securities Purchase Agreement for a registered direct offering of 7,142,858 shares of common stock. The shares are priced at $0.28 per share, aiming for aggregate gross proceeds of approximately $2.0 million before fees and expenses. The offering is conducted under an existing Form S-3 registration statement and is expected to close around May 21, 2026. D. Boral Capital LLC is acting as the placement agent, receiving a 7.0% cash fee and reimbursement for expenses up to $75,000. In connection with the deal, the company, its directors, and executive officers have agreed to a 30-day lock-up period and restrictions on issuing new common stock or equivalents. The proceeds are intended for general corporate purposes. The filing also includes a legal opinion from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. regarding the validity of the shares.